gip/glp-1 agonists GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Frontiers | Clinical perspectives on

Whether you're just starting or looking to enhance your results, this guide is your go-to companion for balanced living after 40.

Obesity is a chronic disease associated with increased risk of obesity-related complications and mortality

Overall, the study supports current guideline flexibility, indicating that both GLP-1RAs and SGLT2 inhibitors provide broadly similar cardiovascular protection

Noom will offer compounded GLP-1 injections paired with Nooms powerful GLP-1 companion program, providing a sustainable pathway off the medications....

GLP-1 drugs like Ozempic and Mounjaro may offer real benefits for people with type 1 diabetes: less insulin, flatter CGM curves, and emerging evidence for heart and kidney protection.

The analysis showed significantly greater WL in the GLP-1RAs group compared to placebo (SMD=0.82, 95% CI 0.23 to 1.42)